Skip to content
Search

Latest Stories

Satisfaction with UK's healthcare system drops significantly: STADA Health Report 2024

Satisfaction with UK's healthcare system drops significantly: STADA Health Report 2024

Difficulties to book appointments, poor standards of care and distrust in policy-makers are major drivers for dissatisfaction in the healthcare system

The STADA Health Report 2024, published today, has revealed a significant decline in satisfaction with national healthcare systems across Europe, with a notable drop seen in the UK, Germany, and Kazakhstan.

According to the report, satisfaction with the UK's healthcare system dropped sharply by 11 percentage points in just one year, falling from 67 percent in 2023 to 56 percent in 2024. This growing dissatisfaction is likely fuelled by “post-pandemic pressure on the National Health Service (NHS).” In 2020, the satisfaction level was at 85 percent.


In terms of discontentment over healthcare, Britain is followed closely by Kazakhstan and Germany, where satisfaction fell by 10 and 8 percent respectively in one year.

Stada iame 2

The 10th annual health report released by global healthcare leader STADA Arzneimittel AG, the parent company of Thornton & Ross, is based on a survey of over 46,000 respondents aged 18 to 99 across 32 countries, with around 2,000 respondents in each country.

A continuous decline in satisfaction levels has been observed since 2021. Overall satisfaction with healthcare systems in Europe was recorded at 74 percent in 2020, just before the pandemic. This figure dropped to 71 percent in 2021, 64 percent in 2022, and 61 percent in 2023.

Today, only 56 percent of Europeans feel satisfied with the healthcare system in their country - the lowest figure in five years - as per the report.

Primary reasons for dissatisfaction included difficulties in booking appointments, inadequate care, staff shortages, and a general lack of trust in healthcare policy-makers.

STADA image 1

In the UK, 69 percent of respondents cited difficulties in booking appointments as the main reason for their dissatisfaction with the healthcare system.

In Germany, 68 percent of respondents cited appointment booking issues, while in Kazakhstan, 61 percent pointed to the standard of care as a major concern.

Hungary Leads in Dissatisfaction

Overall, Hungary emerged as the country with the highest level of dissatisfaction, with 72 percent of respondents describing their national healthcare system as insufficient. Kazakhstan and Serbia follow closely, with 67 percent and 65 percent of respondents respectively expressing similar concerns.

Across Europe, challenges in securing appointments were particularly pronounced in Hungary (73 percent) while inadequate care was most often reported in Sweden (63 percent).

Trust in health policy-makers is notably low, with almost half of Europeans (46 percent) expressing a lack of confidence in those responsible for health policy. This was the most common complaint in the Czech Republic, where 66 percent of respondents shared this view.

Other reasons for Europeans’ dissatisfaction with healthcare systems included a lack of sustainability (39 percent), the impact of healthcare privatization (30 percent), lack of access to preventive services and shortages of medical staff in hospitals (each noted by 28 percent of respondents.)

Countries with the highest levels of satisfaction

Belgium (85 percent), Switzerland (81 percent), and the Netherlands (77 percent) reported the highest levels of satisfaction with their healthcare systems.

Key factors contributing to this positive sentiment are the availability of medication and good advice from healthcare professionals (doctors or pharmacists). Notably, Germany also scores well in medication availability despite some supply shortages (66 vs 56 European average).

Other factors driving healthcare system satisfaction included the affordability of medication (43), which is rated especially high in Belgium (59), and good access to preventive health services (41), which is particularly valued by the Czech population (62).

The report also noted a correlation between satisfaction with healthcare systems and regular self-care practices. “People who regularly engage in self-care are more likely to be happy with the healthcare system (57) than those who reportedly do little to support their own health (47),” it stated.

How to improve healthcare systems in Europe

In addition to addressing the immediate causes of dissatisfaction highlighted in the report, the participants suggested several measures to improve healthcare systems in the future.

Nearly half (48 percent) believe that having health policy-makers with a healthcare background would make a positive difference. Additionally, 47 percent advocated for increased wages for people working in medical professions to motivate more people to pursue a career in healthcare, and 43 percent supported increased domestic production of medicines to reduce reliance on imports.

Stada image 3

Trust in GPs and pharmacists remains strong

Despite widespread dissatisfaction with healthcare systems among Europeans, trust in healthcare professionals remains strong. General practitioners (GPs) and pharmacists continue to be the primary sources of information for purchasing over-the-counter (OTC) medicines and dietary supplements.

The report also highlighted a rising trust in conventional healthcare among Europeans, with 69 percent of respondents expressing complete or mostly complete trust in conventional medicine – a 7-percentage point increase from 2022.

Men (35 percent) were more likely than women (25 percent) to fully trust conventional medicine.

The main reasons for this growing trust are health practitioners such as doctors and pharmacists. According to the survey, 48 percent of Europeans value their advice, believing that healthcare professionals "know what's best."

Furthermore, 42 percent of respondents trust conventional medicine due to its proven effectiveness, 41 percent place because of decades of research resulting in numerous breakthroughs, and 39 percent cited high-quality standards, regulatory processes, and controls as reasons for their trust.

Those who trust conventional medicine are significantly more satisfied with their healthcare system (59 percent) compared to those who have reservations against conventional medicine (28 percent).

To further improve confidence in conventional medicine, 46 percent of Europeans believe it should focus more strongly on individual patient demands and enhance communication during consultations.

Europeans also desire more medical breakthroughs (41 percent), especially in the treatment of serious diseases such as cancer;  a holistic approach to healthcare (40 percent), specialized doctor lists (29 percent), easier access to appointments (28 percent), and more user-friendly medicines (25).

The data also indicated that Europeans are increasingly taking action to care for their health by adopting healthier lifestyles, engaging in more physical exercise, and improving their diets. There is also a growing awareness that physical and mental well-being are equally important.

Peter Goldschmidt, CEO of STADA Arzneimittel AG, said: “I find this trend highly encouraging. I invite all stakeholders—the companies that develop, make and supply essential medicines; the policymakers and regulators who set the frameworks for such products’ use; the doctors who prescribe them; the nurses who administer them; the pharmacists who dispense them; and the patients who benefit from them—to join the debate around the many challenges, but also potential solutions, presented in the 10th edition of the STADA Health Report.”

“Through open dialogue, based on empirical data, together, we build resilient health systems for the years to come. “

The 2024 STADA survey was conducted by Human8 via an online questionnaire in February and March 2024. The survey covered 23 countries: Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Hungary, Ireland, Italy, Kazakhstan, the Netherlands, Po land, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland, the United Kingdom and Uzbekistan.

More For You

Janet Morrison discusses pharmacy funding strategy at 2025 conference

Health Secretary Wes Streeting outlines government support for community pharmacy

CPE calls new funding deal a ‘reluctant yes’

Community Pharmacy England (CPE) was “reluctant” to accept the new pharmacy funding deal due to the significant funding gap, said the organisation’s chief executive Janet Morrison, while recognising the settlement as the first step towards stabilising the sector.

Addressing the 2025 Pharmacy Business Conference on Sunday at London Hilton Wembley, Janet shared insights into the behind-the-scenes work that led to the agreement.

Keep ReadingShow less
RPS transition to Royal College

RPS transition to Royal College: What it means for pharmacy

RPS transition to Royal College: What it means for pharmacy - Professor Claire Anderson explains

The Royal Pharmaceutical Society (RPS) is set to transition into a Royal College after securing majority support from its members in a recent ballot. However, concerns have been raised about the long-term implications of this shift.

With a voter turnout of 31.4%, 6,144 out of 19,594 eligible members participated in the vote on the Royal Charter changes. Of those, 71.1% supported the transition, well above the required two-thirds majority for a Special Resolution Vote.

Keep ReadingShow less
Pharmacies key to driving the shift from treatment to prevention

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe.

Pharmacies can become frontline educators of self-care

Pharmacies have the potential to play a pivotal role in the government's transition from treatment-based healthcare to a more prevention-focused approach. However, for this shift to be successful, they require greater systemic support.

Bas Vorsteveld, Kenvue’s area managing director for Northern Europe, emphasises the importance of allowing pharmacists access to patient records to enable them to offer tailored advice and improve patient care.

Keep ReadingShow less
Community pharmacist consulting with a patient about independent prescribing.

Malcolm Harrison

Exclusive: National prescribing service 'critical' for community pharmacy, says Malcolm Harrison

A national prescribing service is “critical” for community pharmacy with all newly qualified pharmacists becoming independent prescribers from next year, according to Malcolm Harrison, chief executive of the Company Chemist Association (CCA).

“We are encouraging the NHS to work with community pharmacy to explore what that (prescribing service) could look like. There are pilots that are out there at the moment, and I know a number of pharmacies are engaged in those and exploring the different variations of what it could be,” Harrison told Pharmacy Business.

Keep ReadingShow less
Unlocking the potential of technology in pharmacy

Harry McQuillan, chairman, Numark

Technology in pharmacy goes beyond operational improvements

Community pharmacies are expected to take on greater responsibilities to ease pressure on other healthcare services and meet growing patient demands. However, despite their expanding role, they continue to lack adequate financial support.

“While funding negotiations continue, one thing remains clear, technology is key to ensuring pharmacy can thrive in a rapidly evolving healthcare landscape,” said Harry McQuillan, chairman of Numark.

Keep ReadingShow less